Medlumics: Funding, Investors & Team (Sep 2026)
Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Medlumics has raised $23.2M across 2 funding rounds on record, the most recent an undisclosed round of $1.4M announced in Jan 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Medlumics Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Medlumics Funding Rounds
Medlumics raised $21.8M in an undisclosed round announced in Feb 2021.
11 months later, an undisclosed round of $1.4M was announced in Jan 2022.
Medlumics Founders and Leadership Team
Contact details for the Medlumics team: 1 of 1 has an email address on file.
Start 14-day free trial →Medlumics Funding Compared to Other Biotechnology Startups
Medlumics' latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Medlumics in Biotechnology and Madrid
Companies Similar to Medlumics
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Medlumics Funding FAQs
What does Medlumics do?
Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
How much funding has Medlumics raised?
Medlumics has raised $23.2M across 2 rounds on record. The most recent is an undisclosed round of $1.4M announced in Jan 2022.
When did Medlumics last raise funding?
Medlumics' most recent funding round on record is an undisclosed round of $1.4M, announced in Jan 2022.
Who is the CEO of Medlumics?
James Greene is listed as CEO at Medlumics.
Where is Medlumics headquartered?
Medlumics is based in Madrid, Spain.
How many employees does Medlumics have?
Medlumics is in the 11-50 employee band.
How does Medlumics' funding compare to other Biotechnology startups?
Medlumics' latest round of $1.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Medlumics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Medlumics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.